116
193
1,596
536,391
ÇöÀçÁ¢¼ÓÀÚ
: 12 (ȸ¿ø 0)
Àüü±×·ì
¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬±¸¼¾ÅÍ
±è¼ºÈÆ ±³¼ö´Ô
Àüü°Ô½Ã¹°
¿ø±Û¸¸
ÄÚ¸àÆ®¸¸
ȸ¿ø¾ÆÀ̵ð :
±×·ì
°Ô½ÃÆÇ
Á¦¸ñ
À̸§
ÀϽÃ
¾Ï¿¹¹æ¼ÒÀ硦
Àη¾缺
´ëÇпø»ý µî·Ï±Ý Áö¿ø
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ(MRC)ÁöÁ¤ ¼ö¿©½Ä
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
Antiplatelet and Antithrombotic Activity¡¦
ÃÖ°í°ü¸®ÀÚ
09-10
¾Ï¿¹¹æ¼ÒÀ硦
°øÁö»çÇ×
´ëÇпø»ý µî·Ï ¾È³»(MRCÀåÇÐ±Ý °ü·Ã)
ÃÖ°í°ü¸®ÀÚ
08-22
¾Ï¿¹¹æ¼ÒÀ硦
¹ßÇ¥³í¹®
PKCand cofilin activation affects periph¡¦
ÃÖ°í°ü¸®ÀÚ
08-01
¾Ï¿¹¹æ¼ÒÀ硦
Çмú¹ßÇ¥
2007 The 1st International Conference of¡¦
ÃÖ°í°ü¸®ÀÚ
07-31
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
KHU NEWS ¾Ï¿¹¹æ¼ÒÀç°³¹ß¿¬±¸¼¾ÅÍ ±è¼ºÈƱ³¡¦
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
¼¾ÅÍ´º½º
2007³â 2Çбâ ÇÑÀÇ´ë MRC ÀåÇÐ±Ý Áö¿ø ¾È³»
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
°ú±âºÎ, 2007 ±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ 4°³ ½Å±Ô¡¦
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ»ç¾÷ 4°³°úÁ¦ ¼±Á¤
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
Á¤ºÎ ±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ ¼±Á¤
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
¡®¾Ï¡¯ ¿¹¹æ°ú Ä¡·á Çѹæ¼ÒÀç °³¹ß
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
±âÃÊÀÇ°úÇבּ¸¼¾ÅÍ 4°÷ ½Å±Ô ÁöÁ¤
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
¡®¾Ï¿¹¹æ ¼ÒÀç°³¹ß¡¯ ±âÃÊÀÇ°úÇבּ¸¼¾ÅͷΡ¦
ÃÖ°í°ü¸®ÀÚ
07-30
¾Ï¿¹¹æ¼ÒÀ硦
º¸µµÀÚ·á
±âÃÊÀÇ°úÇÐ ¿¬±¸¼¾ÅÍ»ç¾÷ 4°÷ ½Å±Ô ¼±Á¤
ÃÖ°í°ü¸®ÀÚ
07-30
óÀ½
ÀÌÀü
2771
2772
2773
2774
2775
2776
2777
2778
2779
2780
¸Ç³¡